Ledger.Open graph →

SEC Form D · Amendment · filed August 28, 2017

Antiva Biosciences, Inc

Offering

$25.9M

Sold

$14.7M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SOUTH SAN FRANCISCO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Ronald K. Rybar · Fenton, MIDirector William H. Dery · Fenton, MIExec Aaron D. Wirsing · Fenton, MIDirector Benjamin P. Rovinski · South San Francisco, CADirector Brian P. Petty · Fenton, MIDirector Randy D. Hicks · Fenton, MIExec · Director Ronald L. Justice · Fenton, MIDirector Raju D. Gadiraju, Ph.D · South San Francisco, CAExec Steven T. Krause · Fenton, MIExec Thomas P. Mckenney · Fenton, MIDirector Jake J. Saper · Philadelphia, PADirector Mitchell J. Stewart · Philadelphia, PAExec · Director Amish J. Jani · Philadelphia, PAExec Ryan J. Shmeizer · Philadelphia, PADirector Allison B. Nolan · Grand Cayman, Cayman IslandsDirector Ronald Mass · Santa Monica, CADirector Andrew J. Sparacia · Cleveland, OHDirector David J. Swentor · Cleveland, OHExec Benjamin P. Rovinski · South San Francisco, CADirector Raju D. Gadiraju, Ph.D · South San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗